We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Information about ensuring blood and blood component safety.
Guidelines to help mitigate and manage medicine shortages.
How manufacturers should undertake a clinical investigation for a medical device to ensure they comply with medical device regulations.
Cancel a marketing authorisation, traditional herbal registration or parallel import product licence or withdraw a pending submission.
How to apply for a regulatory advice meeting on medical devices and in vitro diagnostic devices.
Information on sourcing medicines that can be supplied by wholesale distributor authorisation (WDA) holders based in the UK.
Information on applying for New Active Substance Work Sharing Initiative (NASWSI) and Biosimilar Work Sharing Initiative (BSWSI) assessments and list of approved products.
Helping manufacturers define the characteristics of their devices and determine the appropriate regulatory qualification and classification.
Webinar recordings providing information about plans for implementing the new Clinical Trial Regulations.
How to register as a manufacturer, importer or distributor of active substances.
Guidance on defining intended purpose for Software as a Medical Device (SaMD), to help SaMD manufacturers in meeting their statutory obligations.
The MMRV vaccine will become part of the routine childhood immunisation schedule in the UK from 1 January 2026.
Guidance on infant and follow-on formula, the application form for infant and follow-on formula made from protein hydrolysates, and forms to notify the authority.
Guidance on submitting an application for approval of a clinical trial that includes an in vitro diagnostic device.
The review of the safety of isotretinoin has concluded.
Safety leaflet on epilepsy medicines and pregnancy to help patients and their families understanding the risks.
Apply for and maintain registrations for the brokering of human medicines.
A series of explainers to help you understand the parts of the MHRA Strategy to 2030 most relevant to you, and what they mean in practice.
Information on clinical trial record retention and archiving requirements including requirements for ownership, data integrity, and transitional provisions.
Requirements for sponsor representatives using EHR (electronic health records) in clinical trials.
Do not include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).